The search for emerging markets is necessary part of growth strategy in IVD. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East.
The countries covered are:
- Egypt
- Iran
- Iraq
- Israel
- Jordan
- Saudi Arabia
- Turkey
- United Arab Emirates (UAE)
- Other Mideast
The Middle East market for in vitro diagnostics is provided in U.S. dollars for the years 2017 – 2022. Also provided is company activities and market drivers.
The report covers six segments of the IVD market in the Middle East:
- Clinical Chemistry
- Immunoassays
- Microbiology
- Point of Care (POC)
- Histology
- Other
The next five to ten years will see moderate and gradual change in global in vitro diagnostic (IVD) product markets. While clinical lab medicine plays an integral role in healthcare and disease management, new testing is difficult to launch in a time of global economic instability and rising healthcare costs. On the supply side, labs are challenged to add new tests with little increase in financial and human resources.
IVD companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care.
Many Middle Eastern countries, such as Saudi Arabia, have identified investment in healthcare infrastructure as a priority, the goal to expand healthcare beyond cities and into desert communities; today roughly 16% of the population is represented by rural areas of the country.
The region's public sector has historically dominated the delivery of healthcare in the Middle East; however, recent activity from governments in the region approaching investors to expand the private sector in health care continues to be encouraging. This is a strategy to diversify and reduce some dependence on the petroleum industry as oil prices continue to be strained. Countries in the region need to create systems that empower the private sector to participate more deeply in the healthcare system. Growth in private sector participation will improve the quality of healthcare and access to it.
Some of the total IVD market growth derives from increased test usage in emerging countries. All of the major IVD companies have reported growth in Turkey and Saudi Arabia, considered two of the top seven emerging markets. These countries continue to invest in healthcare infrastructure and insurance coverage for a growing more affluent middle class.
This development requires increased investment in healthcare. This increased investment most often takes the form of government tenders, which remain a major source ofsupply for state-controlled labs and hospitals. Lifestyle change a more sedentary lifestyle resulting in rising obesity rates has brought about the emergence of “Western” diseases such as diabetes. There is growing demand in the region, therefore, for medical tests.
- Executive Summary
- Overview
- Scope and Methodology
- Size and Growth of the Market
- Table IVD in the Middle East, 2017-2022 CAGR 5.7%
- Middle East: Regional Overview
- Population
- Table Elderly Dependency Ratio in Middle East and Other Select Countries, 2010 and 2050
- Table World Population: Mideast Region (Saudi Arabia, Turkey, Iran, Egypt, Iraq, United Arab Emirates, Israel, Jordan, Other Mideast) , 2005-2025 (million persons)
- Economic Outlook
- Table GDP: Mideast Region (Saudi Arabia, Turkey, Iran, Egypt, Iraq, United Arab Emirates, Israel, Jordan, Other Mideast) (billion US$)
- Major Diseases Affecting the Middle Eastern Population
- Cardiovascular Diseases
- Cancer
- Table The Most Frequent Cancers by Country of Middle East (%) As Reported by National Cancer Registry Programs, 2015
- Diabetes
- Table People Living with Diabetes in Middle East Region and Projections 2045 (millions of people)
- Middle Eastern Respiratory Syndrome (MERS)
- Table Epidemiological Characteristics of MERS Cases Reported Globally, (Dec 2012 - May 2013 through Dec 2017 - May 2018)
- Arab Health Congress
- Population
- Country Market Analysis
- Overview
- Egypt IVD Market
- Table Egypt In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table Egypt - POC Market Distribution, 2017-2022 (%) (POC Glucose, POC Other)
- Market Drivers
- Market Inhibitors
- Market Participant Activity
- Iran IVD Market
- Table Iran In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table Iran - POC Market Distribution, 2017-2022 (%) (POC Glucose, POC Other)
- Market Drivers
- Market Inhibitors
- Iraq IVD Market
- Table Iraq In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total ($ millions)
- Table Iraq - POC Market Distribution, 2017-2022 (%) (POC Glucose, POC Other)
- Market Drivers
- Market Inhibitors
- Market Participant Activity
- Israel IVD Market
- Table Israel In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table Israel - POC Market Distribution, 2017-2022 (%) (POC Glucose, POC Other)
- Market Drivers
- Market Inhibitors
- Market Participant Activity
- Jordan IVD Market
- Table Jordan In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table Jordan - POC Market Distribution, 2017-2022 (%) (POC Glucose, POC Other)
- Market Drivers
- Market Participant Activity
- Saudi Arabia IVD Market
- Table Saudi Arabia In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table Saudi Arabia - POC Market Distribution, 2017-2022 (%) (POC Glucose, POC Other)
- Market Drivers
- Market Inhibitors
- Market Participant Activity
- Turkey IVD Market
- Table Turkey In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table Turkey - POC Market Distribution, 2017-2022 (%) (POC Glucose, POC Other)
- Market Drivers
- Market Inhibitors
- Market Participant Activity
- United Arab Emirates (UAE) IVD Market
- Table United Arab Emirates In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Table United Arab Emirates - POC Market Distribution, 2017-2022 (%) (POC Glucose, POC Other)
- Market Drivers
- Market Participant Activity
- Market Summary: Total Mideast Market
- Summary
- Table Mideast In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
- Clinical Chemistry Market
- Immunoassay Market
- Microbiology Market
- Point-of-Care Market
- Histology Market
- Table Mideast In Vitro Diagnostic Sales by Country, 2017-2022 ($ millions) (Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates, Other Mideast, Total)
- Table Mideast In Vitro Diagnostic Sales by Country, 2017-2022 - Eight Countries Generate more than 80% Market Value (Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates, Other Mideast)
- Summary
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook